Literature DB >> 21556784

Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions.

Chad D Morris1, Jeanette A Waxmonsky, Mandy G May, David G Tinkelman, Miriam Dickinson, Alexis A Giese.   

Abstract

Persons with mental illnesses use tobacco at significantly higher and heavier rates than the general population, and suffer greater tobacco- related morbidity and mortality. However, there are few existing tobacco cessation interventions for these individuals. This study examined two tobacco cessation interventions, a telephonic quitline intervention (counseling and nicotine replacement therapy) and a community-based group counseling intervention with adults currently receiving community mental health services. At 6-month follow-up, both groups demonstrated significantly reduced tobacco use, but participants who received both quitline services and the group counseling intervention were significantly more likely to have a 50% tobacco use reduction. Across groups, the overall intent-to-treat cessation rate was 7%. Tobacco dependence, depression symptoms, and psychotic symptoms decreased significantly for all treatment groups, while health and mental health functioning increased. Findings suggest that common community tobacco cessation services are effective for this population.

Entities:  

Mesh:

Year:  2011        PMID: 21556784     DOI: 10.1007/s10597-011-9411-z

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  63 in total

1.  Ability of smokers to reduce their smoking and its association with future smoking cessation.

Authors:  J R Hughes; K M Cummings; A Hyland
Journal:  Addiction       Date:  1999-01       Impact factor: 6.526

Review 2.  Smoking reduction for smokers not able or motivated to quit?

Authors:  Philip Tønnesen
Journal:  Respiration       Date:  2002       Impact factor: 3.580

3.  Predictors of tobacco use among persons with mental illnesses in a statewide population.

Authors:  Chad D Morris; Alexis A Giese; Jennifer J Turnbull; Miriam Dickinson; Nancy Johnson-Nagel
Journal:  Psychiatr Serv       Date:  2006-07       Impact factor: 3.084

Review 4.  Does smoking reduction increase future cessation and decrease disease risk? A qualitative review.

Authors:  John R Hughes; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2006-12       Impact factor: 4.244

Review 5.  A systematic review of interventions for smokers who contact quitlines.

Authors:  Lindsay F Stead; Rafael Perera; Tim Lancaster
Journal:  Tob Control       Date:  2007-12       Impact factor: 7.552

6.  Tobacco quitlines and persons with mental illnesses: perspective, practice, and direction.

Authors:  Chad D Morris; Gary J Tedeschi; Jeanette A Waxmonsky; Mandy May; Alexis A Giese
Journal:  J Am Psychiatr Nurses Assoc       Date:  2009-02       Impact factor: 2.385

7.  A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.

Authors:  Amanda Baker; Robyn Richmond; Melanie Haile; Terry J Lewin; Vaughan J Carr; Rachel L Taylor; Sylvia Jansons; Kay Wilhelm
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

Review 8.  Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Authors:  G W Dalack; D J Healy; J H Meador-Woodruff
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

9.  Smoking reduction and cessation among young adult women: a 7-year prospective analysis.

Authors:  Liane McDermott; Annette Dobson; Neville Owen
Journal:  Nicotine Tob Res       Date:  2008-09       Impact factor: 4.244

10.  Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.

Authors:  Craig W Colton; Ronald W Manderscheid
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

View more
  14 in total

1.  Persistent disparity in prevalence of current cigarette smoking between US adolescents with vs. without a past-year major depressive episode.

Authors:  Anthony P Polednak
Journal:  Community Ment Health J       Date:  2013-12-13

2.  A Reasonable Alternative to Clozapine in the Chronically Relapsing Smoking Patient? A Retrospective Analysis.

Authors:  John R Tomko; Nadeem Ahmed; Cynthia Kuntz; Justine Zick
Journal:  Hosp Pharm       Date:  2016-11

3.  Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.

Authors:  Joelle C Ferron; Timothy Devitt; Gregory J McHugo; Jessica A Jonikas; Judith A Cook; Mary F Brunette
Journal:  Community Ment Health J       Date:  2016-03-01

Review 4.  Group behaviour therapy programmes for smoking cessation.

Authors:  Lindsay F Stead; Allison J Carroll; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2017-03-31

Review 5.  Interventions for smoking cessation and reduction in individuals with schizophrenia.

Authors:  Daniel T Tsoi; Mamta Porwal; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Peer Supports for Tobacco Cessation for Adults with Serious Mental Illness: A Review of the Literature.

Authors:  Colleen E McKay; Faith Dickerson
Journal:  J Dual Diagn       Date:  2012-05-11

7.  Smoking reduction interventions for smoking cessation.

Authors:  Nicola Lindson; Elias Klemperer; Bosun Hong; José M Ordóñez-Mena; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2019-09-30

8.  Telephone counselling for smoking cessation.

Authors:  William Matkin; José M Ordóñez-Mena; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-05-02

9.  Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness.

Authors:  Mark R Hawes; Kimberly B Roth; Leopoldo J Cabassa
Journal:  J Dual Diagn       Date:  2021-07-19

10.  Smoking cessation for improving mental health.

Authors:  Gemma Mj Taylor; Nicola Lindson; Amanda Farley; Andrea Leinberger-Jabari; Katherine Sawyer; Rebecca Te Water Naudé; Annika Theodoulou; Naomi King; Chloe Burke; Paul Aveyard
Journal:  Cochrane Database Syst Rev       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.